[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100524709":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":23,"locations":22,"responsibleParty":29,"collaborators":22,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":22,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":22,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":22,"overallStatus":52,"whyStopped":22,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":22},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Heparin and Hirudin","EXPERIMENTAL","Anticoagulant in Hemodialysis",[13],"Drug: Heparin",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Heparin","Comparison between heparin and hirudin",[9],[21],"Hirudin",null,[24],{"name":25,"role":26,"phone":27,"phoneExt":22,"email":28},"Basma Rabiey, Master","CONTACT","01128066349","basmarabiey639@gmail.com",{"type":30,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"SPONSOR_INVESTIGATOR","Basma Rabiey","Principal investigator","100524709","early-phase-1-comparison-between-haparin-and-herodin-in-hd-100524709",false,"NCT06112262","Comparison Between Haparin and Herodin in HD","Comparison of the Effecta and Drawbacks of Heparin Versus Hirudin Drugs in Haemodialysis Patients in Assiut University Hospitals","Inclusion Criteria:\n\n1. patient age between 18:70\n2. Haemodialysis duration less than 6 months\n3. Agree to participate in the study\n\nExclusion Criteria:\n\n1. AKI\n2. patients with impaired coagulation profile\n3. Decompensated liver disease","ALL","18 Years","70 Years",{"count":44,"type":45},98,"ESTIMATED","INTERVENTIONAL",[48],"EARLY_PHASE1","The goal of this study is to compare the efficacy and drawbacks of Heparin and Hirudin in Haemodialysis patients. The main question it aims to answer is:\n\nwhich drug is more safe in Haemodialysis?",[51],"Haemodialysis","NOT_YET_RECRUITING","2023-11-19",{"date":55,"type":56},"2023-11-21","ACTUAL",{"date":58,"type":45},"2023-12-20",{"date":60,"type":45},"2026-09",{"name":31,"class":6}]